Thailand Adopts Policy To Restrict Use Of A/H1N1 Antivirals
This article was originally published in PharmAsia News
Executive Summary
Thailand's Public Health Ministry has put in place plans to impose restrictions on the use of antiviral drugs for treating the A/H1N1 flu virus. The restrictions are intended to avoid the virus developing into a drug-resistant version as a result of over-prescribing. Under the plan, the drugs are to be prescribed only after laboratory tests confirm a patient has A/H1N1. Until the new guidelines, the ministry had allowed Roche's Tamiflu (oseltamivir) to be provided to patients who had a high fever and had recently returned from countries where infections were reported. (Click here for more